PMID- 38292592
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20240201
IS  - 2364-3722 (Print)
IS  - 2196-9736 (Electronic)
IS  - 2196-9736 (Linking)
VI  - 12
IP  - 1
DP  - 2024 Jan
TI  - Risk factors of early adverse events associated with endoscopic ultrasound-guided 
      hepaticogastrostomy using self-expandable metal stent.
PG  - E164-E175
LID - 10.1055/a-2240-1100 [doi]
AB  - Background and study aims This retrospective study aimed to investigate risk 
      factors for early adverse events (AEs) associated with endoscopic 
      ultrasonography-guided hepaticogastrostomy (EUS-HGS) using self-expandable metal 
      stents (SEMS). Patients and methods The clinical success rate, technical success 
      rate, and early AEs were assessed at two hospitals from 2010 to 2022. The 
      analysis focused on risk factors associated with cholangitis, peritonitis, and 
      SEMS migration. Results Technical success was achieved in all cases (94/94), and 
      clinical success was 96.8% (91/94). Post-procedural acute cholangitis occurred in 
      12.8%of cases (12/94). However, no statistically significant risk factors were 
      identified for cholangitis or biliary tract infection. Peritonitis occurred in 
      only 2.1% of cases (2/94). Univariate analysis, using a 1.5 cm cut-off for the 
      distance between the liver and gastrointestinal tract, revealed significant risk 
      factors: braided-type SEMS, bile duct diameter (especially >4 mm), 6 mm diameter 
      SEMS, and tract dilation ( P= 0.001, P= 0.020, P =0.023, and P =0.046, 
      respectively). Adjusting the cut-offs to 2 cm underscored braided-type SEMS and 
      tract dilation as risk factors ( P =0.002 and P =0.046, respectively). With 
      2.5-cm cut-offs, only braided-type SEMS remained significant ( P =0.018). 
      Mortality within 14 and 30 days following EUS-HGS was 5.3% (5/94) and 16.0% 
      (15/94), respectively. Conclusions EUS-HGS using SEMS demonstrated high technical 
      and clinical success rates. Laser-cut SEMS may be superior in preventing early 
      AEs.
CI  - The Author(s). This is an open access article published by Thieme under the terms 
      of the Creative Commons Attribution-NonDerivative-NonCommercial-License, 
      permitting copying and reproduction so long as the original work is given 
      appropriate credit. Contents may not be used for commercial purposes, or adapted, 
      remixed, transformed or built upon. 
      (https://creativecommons.org/licenses/by-nc-nd/4.0/).
FAU - Nakaji, So
AU  - Nakaji S
AUID- ORCID: 0000-0001-7955-6092
AD  - Gastroenterology, Kameda Medical Center, Kamogawa, Japan. RINGGOLD: 13770
AD  - Department of Metabolism and Endocrinology, Saga Medical School Faculty of 
      Medicine, Saga University, Saga, Japan. RINGGOLD: 13030
FAU - Takahashi, Hirokazu
AU  - Takahashi H
AD  - Department of Metabolism and Endocrinology, Saga Medical School Faculty of 
      Medicine, Saga University, Saga, Japan. RINGGOLD: 13030
FAU - Yoshioka, Wataru
AU  - Yoshioka W
AD  - Gastroenterology, Kameda Medical Center, Kamogawa, Japan. RINGGOLD: 13770
FAU - Shiratori, Toshiyasu
AU  - Shiratori T
AD  - Gastroenterology, Kameda Medical Center, Kamogawa, Japan. RINGGOLD: 13770
FAU - Yoshimura, Shigenobu
AU  - Yoshimura S
AD  - Gastroenterology, Kameda Medical Center, Kamogawa, Japan. RINGGOLD: 13770
FAU - Kawamitsu, Natsuki
AU  - Kawamitsu N
AD  - Gastroenterology, Kameda Medical Center, Kamogawa, Japan. RINGGOLD: 13770
FAU - Tomonari, Akiko
AU  - Tomonari A
AD  - Department of Gastroenterology, ParkwayHealth China, Shanghai, China. RINGGOLD: 
      159398
LA  - eng
PT  - Journal Article
DEP - 20240130
PL  - Germany
TA  - Endosc Int Open
JT  - Endoscopy international open
JID - 101639919
PMC - PMC10827478
OTO - NOTNLM
OT  - Biliary tract
OT  - Endoscopic ultrasonography
OT  - Intervention EUS
OT  - Pancreas
COIS- Conflict of Interest The authors declare that they have no conflict of interest.
EDAT- 2024/01/31 06:42
MHDA- 2024/01/31 06:43
PMCR- 2024/01/01
CRDT- 2024/01/31 04:13
PHST- 2023/10/09 00:00 [received]
PHST- 2024/01/04 00:00 [accepted]
PHST- 2024/01/31 06:43 [medline]
PHST- 2024/01/31 06:42 [pubmed]
PHST- 2024/01/31 04:13 [entrez]
PHST- 2024/01/01 00:00 [pmc-release]
AID - EIO-2023-10-3171-OA [pii]
AID - 10.1055/a-2240-1100 [doi]
PST - epublish
SO  - Endosc Int Open. 2024 Jan 30;12(1):E164-E175. doi: 10.1055/a-2240-1100. 
      eCollection 2024 Jan.